CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 35 filers reported holding CYTOSORBENTS CORP in Q1 2016. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $70,000 | -93.1% | 22,524 | -80.9% | 0.00% | – |
| Q3 2021 | $1,010,000 | +6633.3% | 117,966 | +6847.3% | 0.00% | – |
| Q1 2021 | $15,000 | -75.8% | 1,698 | -75.4% | 0.00% | – |
| Q4 2020 | $62,000 | +226.3% | 6,898 | +184.1% | 0.00% | – |
| Q3 2020 | $19,000 | -42.4% | 2,428 | -25.9% | 0.00% | – |
| Q2 2020 | $33,000 | +725.0% | 3,278 | +528.0% | 0.00% | – |
| Q1 2020 | $4,000 | -76.5% | 522 | -88.3% | 0.00% | – |
| Q4 2019 | $17,000 | +21.4% | 4,476 | +66.7% | 0.00% | – |
| Q3 2019 | $14,000 | -17.6% | 2,685 | +6.5% | 0.00% | – |
| Q2 2019 | $17,000 | +325.0% | 2,521 | +480.9% | 0.00% | – |
| Q4 2018 | $4,000 | -55.6% | 434 | -35.4% | 0.00% | – |
| Q3 2018 | $9,000 | +350.0% | 672 | +232.7% | 0.00% | – |
| Q2 2018 | $2,000 | -99.3% | 202 | -99.6% | 0.00% | – |
| Q4 2015 | $306,000 | – | 54,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
| Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
| CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
| Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
| Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
| Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
| Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
| Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |